Drug trial aims to make risky heart surgery safer for patients with low platelets
NCT ID NCT07278661
Summary
This study is testing if a drug called romiplostim can safely increase platelet counts in patients with low platelets before they undergo major heart surgery. The goal is to reduce the risk of dangerous bleeding and the need for blood transfusions during and after the operation. About 136 adult patients scheduled for heart surgery with low platelet counts will receive either the drug or a placebo before their procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIRURGICAL INTERVENTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU d'Angers
Angers, France
Contact Email: •••••@•••••
-
CHU de Bordeaux
Bordeaux, France
Contact Email: •••••@•••••
-
CHU de Brest
Brest, France
Contact Email: •••••@•••••
-
CHU de Dijon
Dijon, France
Contact Email: •••••@•••••
-
CHU de Nantes
Nantes, France
Contact Email: •••••@•••••
-
CHU de Rennes
Rennes, France
Contact Email: •••••@•••••
-
CHU de Strasbourg
Strasbourg, France
Contact Email: •••••@•••••
-
Hôpital Bichat (AP-HP)
Paris, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.